Related Experiment Videos

Myeloperoxidase-mediated activation of xenobiotics by human leukocytes

A H Hofstra1, J P Uetrecht

  • 1Faculty of Pharmacy, University of Toronto, Ontario, Canada.

Toxicology
|October 5, 1993
PubMed

Insights

Peripheral blood leukocytes metabolize drugs using enzymes, notably myeloperoxidase (MPO). MPO-generated oxidants can alter drug compounds, potentially contributing to immune-mediated idiosyncratic drug reactions.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Peripheral blood leukocytes possess enzymes crucial for xenobiotic metabolism.
  • Myeloperoxidase (MPO) is identified as a key enzyme in this metabolic process.
  • MPO generates hypochlorous acid, a potent oxidant.

Purpose of the Study:

  • To investigate the role of leukocyte enzymes, particularly MPO, in xenobiotic metabolism.
  • To explore the potential involvement of MPO-generated reactive intermediates in drug reactions.

Main Methods:

  • Analysis of enzyme activities in peripheral blood leukocytes.
  • Characterization of MPO's oxidative capabilities on various compounds.
  • Correlation of xenobiotic metabolism by leukocytes with immune-mediated drug reactions.

Main Results:

  • Leukocytes contain multiple xenobiotic-metabolizing enzymes, with MPO being prominent.
  • MPO effectively oxidizes diverse compounds, especially those with nitrogen and sulfur functional groups.
  • Reactive intermediates from leukocyte xenobiotic metabolism may link to idiosyncratic drug reactions.

Conclusions:

  • Myeloperoxidase plays a significant role in the metabolism of xenobiotics by leukocytes.
  • The oxidative activity of MPO and its generated intermediates are implicated in immune-mediated adverse drug events.
  • Understanding leukocyte xenobiotic metabolism is vital for predicting and managing idiosyncratic drug reactions like drug-induced lupus.

Related Concept Videos